Health Catalyst Inc
$ 1.23
9.82%
15 Apr - close price
- Market Cap 90,511,000 USD
- Current Price $ 1.23
- High / Low $ 1.25 / 1.12
- Stock P/E N/A
- Book Value 3.41
- EPS -2.55
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.04 %
- ROE -0.58 %
- 52 Week High 5.06
- 52 Week Low 0.96
About
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah.
Analyst Target Price
$1.96
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-13 | 2025-11-11 | 2025-08-07 | 2025-05-07 | 2025-02-20 | 2024-11-06 | 2024-08-07 | 2024-05-09 | 2024-02-22 | 2023-10-27 | 2023-08-08 | 2023-05-09 |
| Reported EPS | 0.08 | 0.06 | -0.59 | 0.01 | 0.04 | 0.07 | 0.12 | 0.05 | 0.02 | 0.03 | 0.05 | 0.05 |
| Estimated EPS | 0.0954 | 0.0629 | 0.04 | 0.03 | 0.0764 | 0.1 | 0.08 | 0.03 | -0.0002 | -0.02 | -0.02 | -0.04 |
| Surprise | -0.0154 | -0.0029 | -0.63 | -0.02 | -0.0364 | -0.03 | 0.04 | 0.02 | 0.0202 | 0.05 | 0.07 | 0.09 |
| Surprise Percentage | -16.1426% | -4.6105% | -1575% | -66.6667% | -47.644% | -30% | 50% | 66.6667% | 10100% | 250% | 350% | 225% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.09 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HCAT
2026-04-15 17:09:05
Health Catalyst (HCAT) and ZoomInfo (GTM) stocks saw significant jumps following a "risk-on" sentiment in the markets, fueled by potential peace negotiations between the U.S. and Iran. Investors returned to growth stocks, benefiting companies with high-margin subscription revenue and generative AI integration. Health Catalyst, despite its recent jump, is down 46.7% year-to-date and has experienced high volatility due to geopolitical events and concerns about AI disruption to SaaS models.
2026-04-12 03:39:37
This article reports a significant decrease in the price target for Health Catalyst (HCAT) common stock. The target has been cut by 45.97%, reducing it to $2.14. The information suggests a potentially negative outlook or revised valuation for the company's shares.
2026-04-11 02:12:00
The global patient engagement solutions market is projected to reach $51.69 billion by 2030, growing from $29.33 billion in 2025 at a CAGR of 12%. This growth is fueled by increased digital solution adoption for real-time communication and personalized interactions, despite challenges like high investment costs and a shortage of skilled IT professionals. Key drivers include health management applications, the services segment, and North America leading regional growth due to government initiatives and rising chronic diseases.
2026-04-10 07:40:17
Health Catalyst's stock plummeted after reporting mixed fourth-quarter results and providing a weaker-than-expected outlook for 2026. CEO Dan Burton addressed the ongoing strategic review, confirming that a potential sale of the company is among the options being considered to maximize shareholder value. This news contributed to the significant drop in share price.
2026-04-10 05:12:00
The global patient engagement solutions market is projected to grow from USD 29.33 billion in 2025 to USD 51.69 billion by 2030, at a CAGR of 12%. This growth is driven by increased digital solution adoption for real-time communication and personalized interactions, despite challenges like high investment and a shortage of skilled IT professionals. The services segment is expected to see the highest growth, with North America leading the market due to regulatory support and chronic disease prevalence.
2026-04-10 00:38:39
Shares of Health Catalyst, Commerce, DocuSign, Unity, and Workiva fell due to increased market volatility following reports of a ceasefire breach in the Middle East and concerns over the disruptive potential of Anthropic's new AI agents. Additionally, short seller Michael Burry's comments about Anthropic "eating Palantir's lunch" further impacted market sentiment. Despite the drops, the article suggests that significant price declines can present buying opportunities for high-quality stocks.
